Hormonal replacement therapy in surgical menopause with underlying endometriosis.

Manee Rattanachaiyanont, Rattanachaiyanont M, Tanmahasamut P, Prasong Tanmahasamut, Angsuwatthana S, Surasak Angsuwatthana, Kitirat Techatraisak, Techatraisak K, Suchada Inthawiwat, Inthawiwat S, Leerasiri P, Pichai Leerasiri
Journal of the Medical Association of Thailand = Chotmaihet thangphaet · 2003 · vol. 86(8) , pp. 702–7 · PMID:12948267 · W5582470
article OA: closed CC0 ⤵ 24 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This retrospective study found that hormonal replacement therapy was safe in postmenopausal women with a history of endometriosis, with rare recurrence and no malignant transformation observed, particularly with combined estrogen and progestin regimens.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the effect of hormonal replacement therapy (HRT) regimens in surgical menopause patients with underlying endometriosis. DESIGN: Observational retrospective study. MATERIAL AND METHOD: 123 women with endometriosis after definite surgery (total abdominal hysterectomy with bilateral salpingo-oophorectomy) were followed in the Gynecologic Endocrinology and Menopause clinics. Patients were classified into 4 groups according to HRT regimens, i.e. control (no HRT, n=17), estrogen only (ERT, n=50), cyclic estrogen/progestin regimen (cyclic E/P, n=16), and continuous combined estrogen/progestin (ccE/P, n=24). 12 patients who received more than one regimen and 4 patients who received less than 6 months of HRT were excluded from the study. The information was obtained from the medical records. RESULTS: Mean age at surgery of all patients was 38.9 years old. Mean duration of HRT was 41.2 months. There was no difference in age at surgery or duration of follow-up in each group. There was 1 (2%) case of recurrent endometriosis and 3 (6%) cases of recurrent symptoms in the estrogen only group; none of them required additional surgical treatment. Malignant transformation was not found. CONCLUSIONS: Although the present series is small, it seems that HRT is safe for postmenopausal women with underlying endometriosis. Recurrence of endometriosis has rarely been a problem with HRT, especially in those who received the combination of estrogen and progestin regimens.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hormone Replacement Therapy Hysterectomy Adult Endometriosis Female Humans Middle Aged Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (5)

Cited by (23)

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:44.121522+00:00
License: CC0 · commercial use OK